The Value of Real-World Data in Understanding Prostate Cancer Risk and Improving Clinical Care: Examples from Swedish Registries
Real-world data (RWD), that is, data from sources other than controlled clinical trials, play an increasingly important role in medical research. The development of quality clinical registers, increasing access to administrative data sources, growing computing power and data linkage capacities have...
Main Authors: | Kerri Beckmann, Hans Garmo, Ingela Franck Lissbrant, Pär Stattin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/4/875 |
Similar Items
-
Registries for orphan drugs: generating evidence or marketing tools?
by: Carla E. M. Hollak, et al.
Published: (2020-09-01) -
The Danish Multiple Sclerosis Registry
by: Melinda Magyari, et al.
Published: (2021-01-01) -
Utility of registries for post-marketing evaluation of medicines. A survey of Swedish health care quality registries from a regulatory perspective
by: Nils Feltelius, et al.
Published: (2017-04-01) -
Real-World Outcomes Among Patients with Cystic Fibrosis Treated with Ivacaftor: 2012–2016 Experience
by: Mark Higgins, et al.
Published: (2020-04-01) -
Finnish multiple sclerosis patients treated with cladribine tablets: a nationwide registry study
by: Atula, S., et al.
Published: (2022)